A Stability Analysis of a Modified Version of the Chi-Square Ratio Statistic: Implications for Equivalence Testing of Aerodynamic Particle Size Distribution
- 613 Downloads
Demonstration of equivalence in aerodynamic particle size distribution (APSD; e.g., by comparing cascade impactor (CI) profiles) constitutes one of key in vitro tests for supporting bioequivalence between test (T) and reference (R) orally inhaled drug products (OIDPs). A chi-square ratio statistic (CSRS) was previously proposed for equivalence testing of CI profiles. However, it was reported that the CSRS could not consistently discriminate between equivalent and inequivalent CI profiles. The objective of the overall project was to develop a robust and sensitive methodology for assessing equivalence of APSD profiles of T and R OIDPs. We propose here a modified version of the CSRS (mCSRS) and evaluated systematically its behavior when T and R CI profiles were identical. Different scenarios comprising CI profiles with different number of deposition sites and shapes were generated by Monte-Carlo simulation. For each scenario, the mCSRS was applied to 20,000 independent sets of 30 T and 30 R CI profiles that were identical. Different metrics (including mean and median) of the distribution of 900 mCSRSs (30 T × 30 R) were then evaluated for their suitability as a test statistic (i.e., independent of the number of sites and shape of the CI profile) for APSD equivalence testing. The median of the distribution of 900 mCSRSs (MmCSRS) was one regardless of the number of sites and shape of the CI profile. Hence, the MmCSRS is a robust metric for CI profile equivalence testing when T and R CI profiles are identical and potentially useful for APSD equivalence testing.
KEY WORDSaerodynamic particle size distribution bioequivalence cascade impactor chi-square ratio statistic orally inhaled drug products
- 3.European Medicines Agency. Guideline on the requirements for clinical documentation for orally inhaled products (OIP) including the requirements for demonstration of therapeutic equivalence between two inhaled products for use in the treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults and for use in the treatment of asthma in children and adolescents. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003504.pdf. Accessed 13 June 2012.
- 4.Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry—bioavailability and bioequivalence studies for nasal aerosols and nasal sprays for local action (draft guidance), June 1999. http://www.fda.gov/ohrms/dockets/ac/00/backgrd/36099b1l.pdf. Accessed 13 June 2012.
- 8.Christopher D, Adams W, Amann A, Bertha C, Byron PR, Doub W, et al. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols, Part 3: Final report on a statistical procedure for determining equivalence. AAPS PharmSciTech. 2007;8:65–74.CrossRefGoogle Scholar
- 9.PQRI APSD Profile Comparisons Working Group. Realistic scenarios 1–33 of 55. http://www.pqri.org/commworking/minutes/pdfs/dptc/psdpcwg/Addl/RealisticScenarios1–33of55.pdf. Accessed 13 June 2012.
- 10.PQRI APSD Profile Comparisons Working Group. Realistic scenarios 34–55 of 55. http://www.pqri.org/commworking/minutes/pdfs/dptc/psdpcwg/Addl/RealisticScenarios34–55of55.pdf. Accessed 13 June 2012.
- 11.Pearson K. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philosophical Magazine Series 5. 1900;50:157–75.Google Scholar
- 13.R Development Core Team. R: A language and environment for statistical computing. http://www.r-project.org/. Accessed 13 June 2012.
- 14.Tsong Y. Statistical comparison of particle size distribution profiles. http://www.pqri.org/commworking/minutes/pdfs/dptc/psdpcwg/Addl/DC01-475116-v2-Yi_Tsong_Statistical_Archive_PQRI_Profile_Comparisons.DOC. Accessed 14 June 2012.
- 15.Hollander M, Wolfe DA. Nonparametric statistical methods. 2nd ed. New York: Wiley; 1999. p. 178–86.Google Scholar
- 17.Casella G, Berger R. Statistical inference. 2nd ed. Pacific Grove: Duxbury; 2002. p. 140–205.Google Scholar
- 19.Lee DS. Searching for the Holy Grail of a single PSD profile comparator: technical challenges with the chi-squared ratio approach. Respiratory Drug Delivery IX. 2004;1:161–8.Google Scholar